Specialty ingredient companies are commanding strong valuations due to their clean-label innovation, proprietary expertise, global capabilities and scalable growth plans, despite broader market and economic pressures. GHJ’s Transaction Advisory Services Practice spoke with George Sent and Tyler Howard, investment bankers in the Food, Beverage and Agribusiness space at Cascadia Capital to find out what factors are driving value in the specialty ingredients sector today.

The Cascadia team recently collaborated with GHJ on Capol’s, a Freudenberg Group company and global leader in confectionery coatings, acquisition of Blue Pacific Flavors, a natural and organic flavor systems supplier. George and Tyler discussed the key valuation drivers for Blue Pacific Flavors and how these compare with trends across the specialty flavors and ingredients sector. They also shared their perspectives on sustainability, clean-label positioning and functional health benefits to examine how the emerging trends influence investor valuations. The discussion touched on operational strengths, potential risks and unique challenges encountered during the transaction, offering lessons for industry leaders considering growth or exit strategies.

By combining deal-level detail with sector-wide trends, George and Tyler provided a practical lens on how valuations are evolving in the ingredients market.

What were some of the key valuation drivers at play for Blue Pacific Flavors, and how do these compare with those seen in the broader specialty flavors/ingredients market?

Cascadia Capital: Blue Pacific maintains a strong reputation in the market as a leading flavor and ingredient platform offering natural and organic flavor solutions. The company boasts an outstanding customer list comprised of a combination of long-term, established category leaders and emerging, on-trend brands. For a company of its size, Blue Pacific is exceptionally unique in having a global manufacturing footprint, industry-leading executive team with decades of experience and state-of-the-art development center, which enables it to maintain a comprehensive catalog of natural and organic flavor formulations and act as a true innovation partner to its customers. The company also has an impressive financial profile, with strong, consistent historical growth and a clear, actionable growth plan.

What broader industry trends does this deal highlight, and how do you see those shaping specialty ingredient valuations over the next few years?

Cascadia Capital: We continue to see an influx of interest from international ingredient companies, particularly those based in Europe, seeking to penetrate the U.S. market. Despite recent consumer weariness, the U.S. consumer and emerging brand ecosystem remain highly attractive to international companies pursuing geographic expansion and aiming to capture above-average growth. 

Public ingredient company valuations are currently trading at a discount relative to historical averages, reflecting a combination of sluggish consumption growth, inflationary pressures compressing margins, tariff-related uncertainties and significant long‑term reformulation investments accelerated by the “Make America Healthy Again” movement. However, notwithstanding public market valuations, we see private market valuations remain robust for ingredient companies with differentiated intellectual property, strong margin profiles and above-average topline growth. 

Large-scale ingredient M&A activity has been limited recently as many of these companies are focusing on cost saving initiatives, including divestments of non-core segments. That being said, large ingredient companies remain interested in smaller, bolt-on deals that are synergistic. We expect middle market food ingredient M&A to continue to remain robust and would expect larger scale ingredient deals to be limited until the macro environment improves and ongoing non-core divestments are completed. We are also seeing sustained and growing interest from private equity investors in the food ingredient sector, driven by the appeal of strong free cash flow generation, healthy organic growth and the ability to gain exposure to the broader food industry without the need to underwrite a single consumer brand “winner.”

What should industry leaders take away from this deal as they think about their own growth or exit strategies?

Cascadia Capital: We always recommend business owners engage with third-party advisors in advance of a potential sale process. In the case of Blue Pacific, advisors were engaged well before any formal discussions with potential counterparties commenced. This advance preparation made it possible to thoroughly understand the business, organize and refine the company’s corporate documentation, present clear and reliable financial statements and develop a coherent, compelling growth narrative. It is difficult to overstate the importance of investing the time to build a three‑to‑five‑year growth plan with specific, actionable initiatives that a future buyer or investor can confidently underwrite. Blue Pacific not only had a strong track record of historical performance to leverage, but also a well‑developed and executable growth plan, which was a key driver of value in the transaction.

There is a lot of focus on sustainability, clean-label positioning and functional health benefits — how much do these trends actually factor into how investors value companies in the ingredients sector?

Cascadia Capital: Both strategic corporations and financial investors are actively seeking ingredient companies that provide clean‑label solutions and ingredients with demonstrable functional health benefits. However, it is critical that these on‑trend attributes are underpinned by an attractive, sustainable financial profile. Typically, clean‑label, health‑focused ingredient businesses deliver above‑average revenue growth, gain market share and sustain strong margin structures. The combination of these desirable market attributes with a compelling financial profile is a powerful value driver, in contrast to the branded Consumer Packaged Goods sector, where companies can achieve exceptional topline growth with limited or no profitability and still command premium, forward‑looking valuations.

Were there any unique challenges or surprises in that transaction that shifted your view on what drives value in this space?

Cascadia Capital: Although attributes such as on‑trend ingredients, a strong financial profile and above‑average growth are critical, one factor that is often overlooked is the strength of the organization’s people. For financial investors, backing a capable management team with a clear vision and the ability to execute a growth plan is essential, while large ingredient companies continue to place significant emphasis on attracting and retaining top talent. Blue Pacific has built an exceptional team of professionals with decades of experience across diverse backgrounds, and this depth of talent is clearly reflected in the company’s performance and its strong, collaborative culture.

What operational strengths or risks surfaced during diligence that other companies in the sector should pay attention to?

Cascadia Capital: Building a portfolio of owned intellectual property or proprietary company “know‑how” is highly valued by buyers. This can include distinctive formulation expertise, patents, trademarks or customized manufacturing capabilities, and it is critical to clearly demonstrate differentiated, value‑added competencies to the market.

From a risk‑management standpoint, given volatility surrounding U.S. tariff policy, it is essential for companies to conduct a detailed review of supply‑chain resilience, including an analysis of alternative raw‑material sources to build redundancy and reduce exposure to high‑tariff geographies wherever possible. For businesses experiencing strong growth, such as Blue Pacific, it is also crucial to carefully assess future capacity requirements and the timing and cost of expansion initiatives needed to deliver on the company’s forecast.

SUCCESS REQUIRES COLLABORATION 

In deals, success depends on more than technical expertise; it requires collaborative partners who bring both insight and initiative to the table. Contact GHJ’s Transaction Advisory Services Practice to learn how it helps strengthen client relationships and create long-term value.